
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 983 | 964 | 1084 | 1039 | 1765 | 2578 |
Fund Return | -1.68% | -3.6% | 8.42% | 1.27% | 12.04% | 9.93% |
Place in category | 3600 | 3604 | 1782 | 2380 | 28 | 5 |
% in Category | 99 | 99 | 54 | 84 | 2 | 1 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Acatis Gane Value Event Fonds UI A | 6.5B | 2.48 | 5.95 | 6.34 | ||
Acatis Gane Value Event Fonds UI B | 6.5B | 2.53 | 6.38 | 6.78 | ||
Acatis Gane Value Event Fonds UI C | 6.5B | 2.29 | 4.57 | 6.43 | ||
ACATIS Datini Valueflex Fonds A | 741.02M | -1.55 | 2.12 | 10.76 | ||
GLS Bank Aktienfonds A | 668.87M | 4.71 | -1.63 | 4.70 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Acatis Gane Value Event Fonds UI A | 6.5B | 2.48 | 5.95 | 6.34 | ||
Acatis Gane Value Event Fonds UI B | 6.5B | 2.53 | 6.38 | 6.78 | ||
Acatis Gane Value Event Fonds UI C | 6.5B | 2.29 | 4.57 | 6.43 | ||
ZukunftsPlan I | 3.19B | 3.45 | 10.45 | 7.15 | ||
Siemens DC Balanced | 1.2B | 1.75 | 4.39 | 3.17 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Palantir | US69608A1088 | 6.52 | 79.27 | +3.78% | |
Bitcoin Tracker EUR XBT Provider | SE0007525332 | 4.88 | 3,448.81 | +1.86% | |
UniCredit Bank GmbH | DE000HVB2QF4 | 4.46 | - | - | |
BioNTech | US09075V1026 | 4.06 | 101.06 | -4.08% | |
NVIDIA | US67066G1040 | 4.01 | 108.48 | +1.40% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review